Approval · Notice of Compliance 27892 · 2022
BUPAQ: Notice of Compliance 27892
Issued April 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27892
- Date
- April 1, 2022
- Company
- Richter Pharma Ag
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- VETERGESIC MLULTIDOSE (Ceva Animal Health Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUPAQ | 02526301 | Marketed |
Medicinal ingredients
- BUPRENORPHINE HYDROCHLORIDE 0.3 MG per ML